Skin Cancer News and Research RSS Feed - Skin Cancer News and Research

Skin cancer is the most common type of cancer in the U.S. It occurs in more than a million people each year, including many older people. There are three main types of skin cancer: basal cell carcinoma, squamous cell carcinoma, and melanoma. Of the three, melanoma is the most serious. Skin cancer occurs when abnormal cells form and multiply in an uncontrolled way in the epidermis, or abnormal cells from the epidermis invade the dermis of the skin. Basal cell carcinoma, squamous cell carcinoma, and melanoma are skin cancers that are named for the epidermal cells from which they develop.
Alcohol consumption linked to higher risk of melanoma

Alcohol consumption linked to higher risk of melanoma

Alcohol intake was associated with higher rates of invasive melanoma among white men and women. [More]
New ULB study shows how cancer cell of origin controls malignant transition

New ULB study shows how cancer cell of origin controls malignant transition

Researchers at the Université libre de Bruxelles, ULB define for the first time how the cancer cell of origin controls invasive and metastatic properties of tumor cells. [More]
Study shows new drug combination effective in treating precancerous skin lesions

Study shows new drug combination effective in treating precancerous skin lesions

A combination of two topical drugs that have been in use for years triggers a robust immune response against precancerous skin lesions, according to a new study. The research, from Washington University School of Medicine in St. Louis and Harvard Medical School, shows that the therapy activates the immune system's T cells, which then attack the abnormal skin cells. [More]
Researchers call sun avoidance as emerging health problem in the U.S.

Researchers call sun avoidance as emerging health problem in the U.S.

A landmark study published Friday in the Journal Dermato-Endocrinology has world-renowned researchers calling insufficient sun exposure an emerging health problem in the United States. [More]
Moffitt scientists show how mathematical modeling can predict patient responses to cancer drugs

Moffitt scientists show how mathematical modeling can predict patient responses to cancer drugs

Scientists have significantly improved their understanding of cancer and have developed numerous therapies that have helped to reduce patient mortality; however, the majority of drugs that make it to the clinical trial phase of development fail, despite promising data in laboratory studies. [More]
Common bacteria on human skin may offer protection against diseases

Common bacteria on human skin may offer protection against diseases

There are more and more examples of the ways in which we can benefit from our bacteria. According to researcher Rolf Lood from Lund University in Sweden, this is true for the skin as well. [More]
Study shows many indoor tanning facilities comply with Texas under-18 ban

Study shows many indoor tanning facilities comply with Texas under-18 ban

When female employees of a mystery shopping firm called posing as 17-year-olds interested in tanning, 81 percent of indoor tanning facilities complied with the Texas ban on indoor tanning for those under the age of 18 in a study conducted by The University of Texas MD Anderson Cancer Center. [More]
Dermatologists offer tips to help men develop healthy skin care routines

Dermatologists offer tips to help men develop healthy skin care routines

When it comes to skin care, men have traditionally kept it simple. However, experts say more men are now pursuing healthier, younger-looking skin. [More]
Scientists identify new way to block action of genetic mutations found in most cancers

Scientists identify new way to block action of genetic mutations found in most cancers

Researchers at the University of Illinois at Chicago have identified a new way to block the action of genetic mutations found in nearly 30 percent of all cancers. [More]
Combination of immunotherapy treatments can improve survival in patients with advanced skin cancer

Combination of immunotherapy treatments can improve survival in patients with advanced skin cancer

McMaster University researchers have found that for patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, treatment with a combination of immunotherapy options improves survival and lowers the risk of life-threatening events. [More]
FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

FDA approves expanded use of systemic therapy for treating chronic moderate-to-severe pediatric psoriasis

Amgen today announced that the U.S. Food and Drug Administration has approved the supplemental Biologics License Application for the expanded use of ENBREL (etanercept), making it the first and only systemic therapy to treat pediatric patients (ages 4-17) with chronic moderate-to-severe plaque psoriasis. [More]
Gut microbiome may help improve immunotherapy response in melanoma patients

Gut microbiome may help improve immunotherapy response in melanoma patients

Patients with malignant melanoma - whose disease has spread - are more likely to respond to immunotherapy treatment if they had greater diversity in their gut bacteria, according to new research presented at the National Cancer Research Institute's Cancer Conference in Liverpool. [More]
Combination of immunotherapy options improves survival of patients with deadly forms of skin cancer

Combination of immunotherapy options improves survival of patients with deadly forms of skin cancer

McMaster University researchers have found that for patients diagnosed in the late stages of one of the most common and deadly forms of skin cancer, treatment with a combination of immunotherapy options improves survival and lowers the risk of life-threatening events. [More]
Study questions recommendation against PSA screening

Study questions recommendation against PSA screening

Since the U.S Preventative Services Task Force recommended against prostate-specific antigen (PSA) screening for prostate cancer, there has been a significant decrease in the number of prostate biopsies and prostate cancer surgeries across the nation, report researchers. [More]
TUM scientists uncover novel mechanisms of action for skin disease medication

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body. [More]
British Skin Foundation celebrates 20 years of research

British Skin Foundation celebrates 20 years of research

Sixty percent of British people currently suffer from or have suffered from a skin disease at some point during their lifetime according to a new survey revealed at the British Skin Foundation’s Skin Deep – 20 Years of Research conference on 13th October in London. [More]
Survey reveals inequalities in access to new, life saving drugs for melanoma in Europe

Survey reveals inequalities in access to new, life saving drugs for melanoma in Europe

Over 5000 patients with metastatic melanoma in Europe are denied access to new, life saving drugs every year, according to a survey presented at the ESMO 2016 Congress in Copenhagen. [More]
Pitt researchers show how repair protein finds structural errors in DNA

Pitt researchers show how repair protein finds structural errors in DNA

Researchers at the University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute have demonstrated how Rad4, a protein involved in DNA repair, scans the DNA in a unique pattern of movement called "constrained motion" to efficiently find structural faults in DNA. [More]
New study highlights need for routine skin cancer screening for all transplant patients

New study highlights need for routine skin cancer screening for all transplant patients

A new study from Drexel University College of Medicine suggests all organ transplant recipients, regardless of race, should receive routine, total-body screenings for skin cancer. [More]
Combination of different drugs could improve effect of immunotherapy on skin cancer

Combination of different drugs could improve effect of immunotherapy on skin cancer

The results of studies involving researchers from the MedUni Vienna and Vienna General Hospital Comprehensive Cancer Center show that the effect of immunotherapy on malignant melanoma (black skin cancer) can be improved by combining it with other cancer treatments. [More]
Advertisement